Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
TVAX Biomedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'TVAX Biomedical, Inc. - Product Pipeline Review - 2014', provides an overview of the TVAX Biomedical, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of TVAX Biomedical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of TVAX Biomedical, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of TVAX Biomedical, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the TVAX Biomedical, Inc.'s pipeline products Reasons to buy - Evaluate TVAX Biomedical, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of TVAX Biomedical, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the TVAX Biomedical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of TVAX Biomedical, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of TVAX Biomedical, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of TVAX Biomedical, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 TVAX Biomedical, Inc. Snapshot 5 TVAX Biomedical, Inc. Overview 5 Key Information 5 Key Facts 5 TVAX Biomedical, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 TVAX Biomedical, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 TVAX Biomedical, Inc. - Pipeline Products Glance 10 TVAX Biomedical, Inc. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 TVAX Biomedical, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 TVAX Biomedical, Inc. - Drug Profiles 12 TVI-Brain-1 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 TVI-Breast-1 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 TVI-Colon-1 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 TVI-Kidney-1 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 TVI-Lung-1 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 TVI-Melanoma-1 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 TVI-Ovary-1 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 TVI-Prostate-1 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 TVI-Hepatitis-1 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 TVI-HIV-1 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 TVI-Tuberculosis-1 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 TVAX Biomedical, Inc. - Pipeline Analysis 24 TVAX Biomedical, Inc. - Pipeline Products by Route of Administration 24 TVAX Biomedical, Inc. - Pipeline Products by Molecule Type 25 TVAX Biomedical, Inc. - Recent Pipeline Updates 26 TVAX Biomedical, Inc. - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 29 Disclaimer 29
List of Tables TVAX Biomedical, Inc., Key Information 5 TVAX Biomedical, Inc., Key Facts 5 TVAX Biomedical, Inc. - Pipeline by Indication, 2014 7 TVAX Biomedical, Inc. - Pipeline by Stage of Development, 2014 8 TVAX Biomedical, Inc. - Monotherapy Products in Pipeline, 2014 9 TVAX Biomedical, Inc. - Phase II, 2014 10 TVAX Biomedical, Inc. - Preclinical, 2014 11 TVAX Biomedical, Inc. - Pipeline by Route of Administration, 2014 24 TVAX Biomedical, Inc. - Pipeline by Molecule Type, 2014 25 TVAX Biomedical, Inc. - Recent Pipeline Updates, 2014 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.